FDA 483 OBSERVATION · #485 OF 1,000 MOST-CITED
Lack of System for Timely Submission of Reports
FDA cited this observation 39 times across 38 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
How FDA worded it — real examples
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
The written MDR procedure does not include an internal system which provides for timely transmission of complete medical device reports to FDA.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.